Navigation Links
Tuberculosis: A neglected pandemic

The German Center for Research and Innovation (GCRI), in cooperation with the Max Planck Florida Institute, will host a discussion on the treatments and challenges of tuberculosis on Thursday, March 31, from 7:00 to 9:00 p.m. The event will take place at the German House New York (871 United Nations Plaza, First Avenue, btw. 48th & 49th Streets).

Tuberculosis, along with HIV/AIDS, is one of today's deadliest threats. Killing one person every 20 seconds, 10 million new cases of active TB develop each year worldwide, of which one quarter are fatal. While treatments are available, numbers of multi-drug resistant infections are on the rise. What are the challenges researchers face in developing a cure? What advances are being made, and how will they impact the developed and developing world? Join highly cited immunologist Prof. Stefan H.E. Kaufmann (Max Planck Institute for Infection Biology) and Robert Koch Award recipient Dr. Carl Nathan (Weill Cornell Medical College) for answers to these questions and insight into the global state of immunobiology. Prof. Kaufmann, who is the founding director and director of the Department of Immunobiology of the Max Planck Institute for Infection Biology in Berlin, is also the president of the International Union of Immunological Societies (IUIS). His scientific interests include immunity to bacterial pathogens with an emphasis on tuberculosis and rational vaccine design. Dr. Nathan's current research focuses on the biochemical basis of the Mycobacterium tuberculosis strain's resistance to treatment. He is the R.A. Rees Pritchett Professor and chairman of the Department of Microbiology and Immunology at Weill Cornell Medical College in New York. Dr. Ann Ginsberg, Chief Medical Officer of the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership focused on the discovery and development of improved treatments for TB and ensuring their affordability for patients around the world, will moderate.


Contact: Andrea Deierlein
German Center for Research and Innovation

Related medicine news :

1. Financial planning a key but neglected component of Alzheimers care, say researchers
2. Good Foster Care Helps Neglected Kids Thrive
3. SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting
4. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
5. Report Calls High Blood Pressure a Neglected Disease
6. IOM report declares high blood pressure a neglected disease
7. Effectiveness of wastewater treatment may be damaged during a severe flu pandemic
8. Pandemic flu strain could point way to universal vaccine
9. Over-reactive immune system kills young adults during pandemic flu
10. NIH scientists explore 1510 influenza pandemic and lessons learned
11. A comparison of severe outcomes during the waves of pandemic (H1N1) 2009
Post Your Comments:
(Date:12/1/2015)... CHICAGO (PRWEB) , ... December 01, 2015 , ... ... risk quantification and optimization of adjunctive imaging is the focus of numerous abstracts ... (RSNA) meeting, November 29-December 4, 2015. Nine abstracts highlight the use of ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch ... product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December ... the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis ... celebrates exceptional special needs providers that excel in synthesizing the areas of clinical ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VIEJO, Calif. , Dec. 1, 2015 /PRNewswire/ ... the prevalence of symptoms for pseudobulbar affect (PBA), ... outbursts of laughing and/or crying resulting from certain ... use of antipsychotic medications in nursing home residents, ... Geriatric Psychiatry. The study showed that almost one ...
(Date:12/1/2015)... , Dec. 1, 2015 Research and ... of the "2016 Global Enteric Disease Testing ... Salmonella, Shigella, Vibrio, Yersinia--France, Germany, Italy, Japan, Spain, ... Japan . --> ... The report is based on a combination ...
(Date:12/1/2015)... UPPSALA, Sverige, December 1, 2015 ... Breast Cancer Study Group (IBCSG, Bern ... att ingå i en klinisk studie av palbociclib, ... --> Studien, med namn PYTHIA, ... med anti-hormonella läkemedel i kombination med palbociclib, som ...
Breaking Medicine Technology: